• +971 0000 000 000
  • info@verticaljournal.top

Director of Sarepta Therapeutics Purchased $3.94M In Stock

Grand News Network | November 6, 2023

Richard Barry, Director at Sarepta Therapeutics (NASDAQ:SRPT), reported a large insider buy on November 6, according to a new SEC filing.

What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Monday showed that Barry purchased 50,000 shares of Sarepta Therapeutics. The total transaction amounted to $3,940,500.

Sarepta Therapeutics shares are trading up 3.87% at $81.03 at the time of this writing on Monday morning.

Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.

Why Insider Transactions Are Important

Insider transactions shouldn't be used primarily to make an investing decision, however an insider ...

Full story available on Benzinga.com


Disclaimer: The views, recommendations, and opinions expressed in this content belong solely to the third-party experts. This site was not involved in the writing and production of this article.


Disclaimer Press Release Banner